Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Lechleitner, M; Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S.
[Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):39-46
Doi: 10.1007/s00508-019-1492-7
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Fröhlich-Reiterer Elke
- Mader Julia
- Pieber Thomas
- Sourij Harald
- Toplak Hermann
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The present article is a recommendation of the Austrian Diabetes Association for the practical use of insulin in type 2 diabetes, including the various insulin regimens.
- Find related publications in this database (using NLM MeSH Indexing)
- -
- Diabetes Mellitus, Type 2 - drug therapy
- Dose-Response Relationship, Drug -
- Drug Administration Schedule -
- Humans -
- Hypoglycemic Agents - therapeutic use
- Insulin - therapeutic use
- Practice Guidelines as Topic -
- Find related publications in this database (Keywords)
- Insulin therapy and type2 diabetes mellitus